NCI Launches Early Investigator Advancement Program, Accepting Applications Until December 31
EIAP Aims to Facilitate the Advancement of Scientists from Diverse Backgrounds With the support of the Equity Council, NCI is launching the Early Investigator Advancement Program (EIAP) to facilitate the advancement of scientists from diverse backgrounds to become independent investigators.
The cancer research enterprise needs a continuous flow of talent through the research career pipeline to thrive. One critical juncture is the transition from junior investigator to independent investigator. Each year, EIAP will support the professional and career development of a cohort of eligible and qualified Early Stage Investigators and New Investigators from institutions across the country. The EIAP aims to: Enhance professional skills; Guide preparation of an R01 grant application; Provide access to a mentoring and peer network; and Grow a community of emerging independent investigators from diverse backgrounds. Applications to the EIAP must be submitted by December 31, 2021. The target start date will be March 1, 2022. The EIAP will hold a pre-application webinar on December 9, 2021, from 4:00-5:00 pm Eastern. Potential applicants should visit the EIAP webpage for information about eligibility, application instructions, and the webinar link, which will be available very soon.
NCI values diversity and particularly encourages applicants from populations underrepresented in the biomedical sciences, as noted in the NIH’s Notice of Interest in Diversity (NOT-OD-20-031).
Contact: Dr. Alison Lin, EIAP@nih.gov